Estimates Revisions Amarin Corporation plc
Stocks
AMRN
US0231114044
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 21/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 13.48 USD | -1.10% |
|
-2.32% | -3.40% |
| 09-10 | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
| 09-08 | Amarin, Kruengkao Form JV to Expand Entertainment Business | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- AMRN Stock
- Consensus Amarin Corporation plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
